Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
1,425,998
-
Shares change
-
+319,706
-
Total reported value, excl. options
-
$70,061,995
-
Value change
-
+$15,568,071
-
Number of buys
-
37
-
Number of sells
-
-14
-
Price
-
$45.94
Significant Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q4 2020
67 filings reported holding IDNA - ISHARES TR - GENOMICS IMMUN as of Q4 2020.
ISHARES TR - GENOMICS IMMUN (IDNA) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,425,998 shares
.
Largest 10 shareholders include Thrivent Financial for Lutherans (417,477 shares), UBS Group AG (186,765 shares), RETIREMENT CAPITAL STRATEGIES (92,174 shares), LPL Financial LLC (81,001 shares), BANK OF AMERICA CORP /DE/ (78,032 shares), ROYAL BANK OF CANADA (68,732 shares), Wealthcare Advisory Partners LLC (55,097 shares), FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. (49,170 shares), STRATEGIC WEALTH MANAGEMENT INC (45,501 shares), and STIFEL FINANCIAL CORP (37,234 shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.